1. Неонатология. Национальное руководство в 2-х томах. 2-е изд. перераб. и доп./по. ред. Володина Н.Н., Дегтярева Д.Н. - Москва, ГЭОТАР-Медиа, 2023 - Т. 1. 752 p.

2. Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA H.H. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update.//Neonatology. 2023. Vol. 120, N 1. P. 3 - 23.

3. Donda K, Vijayakanthi N, Dapaah-Siakwan F, Bhatt P, Rastogi D R.S. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States.//Pediatr Pulmonol. 2019. Vol. 54, N 4. P. 405 - 414.

4. Kumar, A., Vishnu Bhat B. Epidemiology of respiratory distress of newborns.//Indian J Pediatr. 1996. Vol. 63. P. 93 - 98.

5. Stoelhorst GM, Rijken M, Martens SE, Brand R, den Ouden AL, Wit JM V.S. Leiden Follow-Up Project on Prematurity. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age < 32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematu//Pediatrics. 2005. Vol. 115, N 2. P. 396 - 405.

6. Avery ME M.J. Surface properties in relation to atelectasis and hyaline membrane disease.//Am. J. Dis. Child. 1959. Vol. 97. P. 517 - 523.

7. Verlato G. et al. Kinetics of surfactant in respiratory diseases of the newborn infant//J. Matern. Neonatal Med. 2004. Vol. 16, N SUPPL. 2. P. 21 - 24.

8. Nogee LM. Genetic causes of surfactant protein abnormalities.//Curr Opin Pediatr. 2019. Vol. 31, N 3. P. 330 - 339.

9. Gruenwald P. Surface tension as a factor in the resistance of neonatallungs to aeration.//Am. J. Obs. Gynecol. 1947. Vol. 53. P. 996 - 1007.

10. PattleRE. Properties, function and origin of the alveolar lining layer.//Nature. 1955. Vol. 175. P. 1125 - 1126.

11. Macklin CC. The pulmonary alveolar mucoid film and the pneumonocytes.//Lancet 1954. 1954. P. 1099 - 1104.

12. Sweet D.G. et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update//Neonatology. 2017. Vol. 111, N 2. P. 107 - 125.

13. Yadav S L.B. Neonatal Respiratory Distress Syndrome. 2020.

14. Stylianou-Riga P. et al. Maternal and neonatal risk factors for neonatal respiratory distress syndrome in term neonates in Cyprus: a prospective case-control study//Ital. J. Pediatr. 2021. Vol. 47, N 1. P. 129.

15. Weng M. et al. Maternal prenatal systemic inflammation indexes predicts premature neonatal respiratory distress syndrome//Sci. Reports. 2024. Vol. 14, N 1. P. 18129.

16. , Cipriani S, Colnaghi M, , Zanini R, Bulfoni C, Parazzini F M.F. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants?//J Matern Fetal Neonatal Med. 2017. Vol. 30, N 11. P. 1267 - 1272.

17. Ross N, Suresh SC D.A. History of respiratory problems in prior infant and respiratory morbidity in subsequent pregnancy.//Am J Obs. Gynecol MFM. 2022. Vol. 4, N 2. P. 100544.

18. Sarno L, Della Corte L, Saccone G, Sirico A, Raimondi F, Zullo F, Guida M, Martinelli P M.G. Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and Meta-analysis.//J Matern Fetal Neonatal Med. 2021. Vol. 34, N 22. P. 3803 - 3812.

19. Никонец А.Д., Балашова Е.Н., Ионов О.В., Киртбая А.Р., Зубков В.В., Шмаков Р.Г. Д.Д.Н. Профилактика дыхательных нарушений у поздних недоношенных детей, рожденных у матерей с врастанием плаценты.//Акушерство и гинекология. 2024. Vol. 1. P. 90 - 100.

20. Gould AJ, Ding JJ, Recabo O, Has P, Savitz DA, Danilack VA L.A. Risk factors for respiratory distress syndrome among high-risk early-term and full-term deliveries.//J Matern Fetal Neonatal Med. 2022. Vol. 35, N 26. P. 10401 - 10405.

21. Hedstrom A.B. et al. Performance of the Silverman Andersen Respiratory Severity Score in predicting PCO2 and respiratory support in newborns: A prospective cohort study////J. Perinatol. Springer US. 2018. Vol. 38, N 5. P. 505 - 511.

22. Завьялов О.В., Игнатко И.В., Ильенко Л.И. П.И.Н. Шкала Сильвермана-Андерсен в оценке синдрома дыхательного расстройства недоношенных новорожденных: клиническое и прогностическое значение.//Акушерство, Гинекология и Репродукция. 2023. Vol. 17, N 3. P. 357 - 365.

23. Setty S.G., Batra M. H.A.B. The Silverman Andersen respiratory severity score can be simplified and still predicts increased neonatal respiratory support.//Acta Paediatr. Int. J. Paediatr. 2020. Vol. 109, N 6. P. 1273 - 1275.

24. Silverman W.A. A.D.H. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants.//Pediatrics. 1956. Vol. 17, N 1. P. 1 - 10.

25. Downes J.J. et al. Respiratory distress syndrome of newborn infants. I. New clinical scoring system (RDS score) with acid--base and blood-gas correlations.//Clin. Pediatr. (Phila). United States. 1970. Vol. 9, N 6. P. P. 325 - 331.

26. Felman A. H., Kirkpatrick B. V. E.D. V. Blood gas studies in neonatal respiratory distress: a clinical-roentgenographic correlation//Am. J. Roentgenol. 1974. Vol. 120, N 2. P. 279 - 284.

27. Boston R. W., Geller F. S.C.A. Arterial blood gas tensions and acid-base balance in the management of the respiratory distress syndrome//J. Pediatr. 1966. Vol. 68, N 1. P. 74 - 89.

28. Beca J. P. S.J.W. Serial determinations of blood lactate in respiratory distress syndrome.//Arch. Dis. Childhood. 1972. Vol. 47, N 254. P. 550 - 557.

29. Al. van der L.N.M. et. Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study.//BMC Pediatr. 2010. Vol. 10. P. 1 - 7.

30. Polin R.A. Management of neonates with suspected or proven early-onset bacterial sepsis//Pediatrics. 2012. Vol. 129, N 5. P. 1006 - 1015.

31. Hornik, Christoph P.; Benjamin, Daniel K.; Becker K.C. Use of the Complete Blood Cell Count in Early-onset Neonatal Sepsis//Pediatr. Infect. Dis. J. 2012. Vol. 31, N 8. P. 799 - 802.

32. Newman T.B. et al. Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: Use of the I/T2//Pediatr. Infect. Dis. J. 2014. Vol. 33, N 8. P. 798 - 802.

33. Володин Н.Н., Долгов В.В. Д.Д.. Белки "острой фазы" воспаления при бактериальных инфекциях у новорожденных детей//Российский вестник перинатологии и педиатрии. 2000. Vol. 45, N 1. P. 10 - 13.

34. Hofer N. et al. An update on the use of C-reactive protein in early-Onset neonatal sepsis: Current insights and new tasks//Neonatology. 2012. Vol. 102, N 1. P. 25 - 36.

35. Hooven T.A., Polin R.A. Pneumonia//Semin. Fetal Neonatal Med. 2017. Vol. 22, N 4. P. 206 - 213.

36. Sarkar S. et al. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis//J. Perinatol. 2006. Vol. 26, N 1. P. 18 - 22.

37. Антонов А.Г., Буров А.А., Володин Н.Н. Г.В.В. и др. Реанимация и стабилизация состояния новорожденных детей в родильном зале. Методическое письмо/под ред. проф. Е.Н. Байбариной//Неонатология: Новости. Мнения. Обучение. 2020. Vol. 8, N 1(27). P. 34 - 52.

38. Sweet D.G. et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update//Neonatology. 2019. Vol. 115, N 4. P. 432 - 450.

39. Bauman W.A. N.J. Chest radiography of prematures; a planned study of 104 patients including clinico-pathologic correlation of the respiratory distress syndrome.//Pediatrics. 1958. Vol. 21, N 5. P. 813 - 824.

40. Roggini M, Pepino D, D'Avanzo M, Andreoli GM, Ceccanti S C.P. Respiratory distress in newborn: evaluation of chest X-rays.//Minerva Pediatr. 2010. Vol. 62, N 3. P. 217 - 219.

41. Czarnecki Assessment of chest X-ray images in newborns with respiratory disorders.//Kardiochir Torakochirurgia Pol. 2015. Vol. 12, N 1. P. 83 - 86.

42. Agrons GA, Courtney SE, Stocker JT M.R. From the archives of the AFIP: Lung disease in premature neonates: radiologic-pathologic correlation.//Radiographics. 2005. Vol. 25, N 4. P. 1047 - 1073.

43. Anton O. et al. Heart rate monitoring in newborn babies: a systematic review.//Neonatology. 2019. Vol. 116, N 3. P. 199 - 210.

44. Joshi R. et al. Monitoring the respiratory rate of preterm infants using an ultrathin film sensor embedded in the bedding: a comparative feasibility study.//Physiol. Meas. 2019. Vol. 40, N 4. P. С. 045003.

45. Gibson K. et al. Non-contact heart and respiratory rate monitoring of preterm infants based on a computer vision system: A method comparison study.//Pediatr. Res. 2019. Vol. 86, N 6. P. С. 738 - 741.

46. Shah S. et al. Comparison of Invasive Arterial Blood Pressure Monitoring vs. Non-Invasive Blood Pressure Monitoring in Preterm Infants< 37 Weeks in the Neonatal Intensive Care Unit-A Prospective Observational Study.//J. Trop. Pediatr. 2021. Vol. 67, N 6. P. С. fmab109.

47. van Zadelhoff A. C. et al. Age-dependent changes in arterial blood pressure in neonates during the first week of life: reference values and development of a model.//Br. J. Anaesthesia. 2023. Vol. 130, N 5. P. 585 - 594.

48. Sola A. et al. Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia?//Acta Paediatr. 2014. Vol. 103, N 10. P. С. 1009 - 1018.

49. Finer N. L.T. Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice.//Pediatr. Res. 2009. Vol. 65, N 4. P. С. 375 - 380.

50. Perrone S. et al. Management of oxygen saturation monitoring in preterm newborns in the NICU: the Italian picture.//Ital. J. Pediatr. 2021. Vol. 47, N 1. P. C. 104.

51. O'Brien E. A. et al. Body temperatures of very low birth weight infants on admission to a neonatal intensive care unit.//J. Matern. Neonatal Med. 2019. Vol. 32, N 16. P. С. 2763 - 2766.

52. Phoya F. et al. Association of neonatal hypothermia with morbidity and mortality in a tertiary hospital in Malawi.//J. Trop. Pediatr. 2020. Vol. 66, N 5. P. С. 470 - 478.

53. Laptook A. R. et al. Admission temperature of low birth weight infants: predictors and associated morbidities.//Pediatrics. 2007. Vol. 119, N 3. P. С. e643 - e649.

54. Ismail R, Murthy P, Abou Mehrem A, Liang Z S.A. Fluid handling and blood flow patterns in neonatal respiratory distress syndrome versus transient tachypnea: a pilot study.//BMC Pediatr. 2021. Vol. 21, N 1. P. 541.

55. de Siqueira Caldas J. P. et al. Admission hypothermia, neonatal morbidity, and mortality: evaluation of a multicenter cohort of very low birth weight preterm infants according to relative performance of the center.//Eur. J. Pediatr. 2019. Vol. 178. P. С. 1023 - 1032.

56. Abiramalatha T. et al. Delivery room interventions for hypothermia in preterm neonates: a systematic review and network meta-analysis.//JAMA Pediatr. 2021. Vol. 175, N 9. P. С. e210775 - e210775.

57. Singh, Y.; Dauengauer-Kirliene, S.; Yousef N. Setting the Standards: Neonatal Lung Ultrasound in Clinical Practice.//Diagnostics. 2024. Vol. 14. P. 1413.

58. , , Guerediaga IS, Gato JM, Fanjul JR, Bilbao VA, Quintela PA O.A. Pulmonary Ultrasound Section of the Neonatal Ultrasound Working Group of the Spanish Society of Neonatology. Usefulness of lung ultrasound in the diagnosis and follow-up of respiratory diseases in neonates.//An Pediatr (Engl Ed). 2022. Vol. 96, N 3. P. 252.e1 - e252.e13.

59. Liu J. Ultrasound diagnosis and grading criteria of neonatal respiratory distress syndrome.//J Matern Fetal Neonatal Med. 2023. Vol. 36, N 1. P. 2206943.

60. Guo BB, Pang L, Yang B, Zhang C, Chen XY, OuYang JB W.C. Lung Ultrasound for the Diagnosis and Management of Neonatal Respiratory Distress Syndrome: A Minireview.//Front Pediatr. 2022. Vol. 14, N 10. P. 864911.

61. Liu J., Li J. S.R.Y. Multi-center prospective study of ultrasonic diagnosis and grading of neonatal respiratory distress syndrome.//Chin Pediatr Emerg Med. 2020. Vol. 27. P. С. 801 - 807.

62. Brat R, Yousef N, Klifa R, Reynaud S, Shankar Aguilera S D.L.D. Lung Ultrasonography Score to Evaluate Oxygenation and Surfactant Need in Neonates Treated With Continuous Positive Airway Pressure.//JAMA Pediatr. 2015. Vol. 169, N 8. P. e151797.

63. Ayoub D, Elmashad A, Rowisha M, Eltomey M E.A.D. Hemodynamic effects of high-frequency oscillatory ventilation in preterm neonates with respiratory distress syndrome.//Pediatr Pulmonol. 2021. Vol. 56, N 2. P. 424 - 432.

64. Winberg P, Sonesson SE L.B. Postnatal changes in intracranial blood flow velocity in preterm infants.//Acta Paediatr Scand. 1990. Vol. 79, N 12. P. 1150 - 1155.

65. Krediet TG, Kavelaars A, Vreman HJ, Heijnen CJ van B.F. Respiratory distress syndrome-associated inflammation is related to early but not late peri/intraventricular hemorrhage in preterm infants.//J Pediatr. 2006. Vol. 148, N 6. P. 740 - 746.

66. Deng Y, Zhang H, Zhao Z, Du J, Bai R M.P. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.//Eur J Pediatr. 2022. Vol. 181, N 8. P. 3131 - 3140.

67. Shimada S, Kasai T, Konishi M F.T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.//J Pediatr. 1994. Vol. 125, N 2. P. 270 - 277.

68. Chen C, Cui Y, Chen S, Chen J, Zhao L, Sun Y, Ji L W.G. Combination of echocardiography with systemic hemodynamic parameters for early risk stratification of hemodynamically significant patent ductus arteriosus in preterm infants.//Front Pediatr. 2025. Vol. 13. P. 1616706.

69. Poon CY, Wilson DG, Joshi S, Fraser AG K.S. Longitudinal evaluation of myocardial function in preterm infants with respiratory distress syndrome.//Echocardiography. 2019. Vol. 36, N 9. P. 1713 - 1726.

70. Cleary GM, Higgins ST, Merton DA, Cullen JA, Gottlieb RP B.S. Developmental changes in renal artery blood flow velocity during the first three weeks of life in preterm neonates.//J Pediatr. 1996. Vol. 129, N 2. P. 251 - 257.

71. Min J, Cho MH, Bae SP, Shin SH, Ha IS, Cheong HI K.H. A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.//J Korean Med Sci. 2020. Vol. 35, N 32. P. e283.

72. Saugstad OD, Kapadia V O.J. Oxygen in the First Minutes of Life in Very Preterm Infants.//Neonatology. 2021. Vol. 118, N 2. P. 218 - 224.

73. Dekker J, Martherus T, Lopriore E G.M., McGillick EV, Hutten J et al. The effect of initial high versus low FiO2 on breathing effort in preterm infants at birth: a randomized controlled trial.//Front Pediatr. 2019. Vol. 12, N 7. P. 504.

74. Hazinski M. F. et al. Part 1: executive summary: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations.//Circulation. 2015. Vol. 132, N 16. P. С. S2 - S39.

75. G.M. et al. Non-invasive versus invasive respiratory support in preterm infants at birth: Systematic review and meta-analysis//BMJ. 2013. Vol. 347, N October. P. 1 - 8.

76. Subramaniam P, Ho JJ D.P. Prophylactic or very early initiation of Continuous Positive Airway Pressure (CPAP) for preterm infants.//Cochrane Database Syst Rev. 2021. Vol. 10, N 10. P. CD001243.

77. , Szczapa T H.R., Borszewska-Kornacka MK R.M. Fraction of inspired oxygen as a predictor of CPAP failure in preterm infants with respiratory distress syndrome: a prospective multicenter study.//Neonatology. 2019. Vol. 116, N 2. P. 171 - 178.

78. Dell'Orto V, Nobile S, Correani A, Marchionni P, Giretti I, Rondina C et al. Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.//Pediatr Pulmonol. 2021. Vol. 56, N 12. P. 3879 - 3886.

79. Madar J. et al. European Resuscitation Council Guidelines 2021: Newborn resuscitation and support of transition of infants at birth.//Resuscitation. 2021. Vol. 161. P. С. 291 - 326.

80. Klebermass К., Wald M., Schwindt J., Grill A., Prusa A.-R. H.N. et al. Less Invasive Surfactant Administration in Extremely Preterm Infants: Impact on Mortality and Morbidity.//Neonatology. 2013. Vol. 103. P. P 252258.

81. Ионов О.В., Косинова Т.А., Киртбая А.Р., Балашова Е.Н., Рындин А.Ю., Зубков В.В. Б.Е.Н. Результаты внедрения протокола стабилизации глубоконедоношенных новорожденных в родильном зале, включающего использование продленного вдоха по показаниям.//Неонатология новости, мнения, обучение. 2019. Т. 7. N 2 (24). 2019. Vol. 7, N 2 (24). P. С. 33 - 41.

82. Mehler K, Grimme J, Abele J, Huenseler C, Roth B K.A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life.//Acta Paediatr. 2012. Vol. 101, N 12. P. 1232 - 1239.

83. Bamat N, Fierro J, Mukerji A, Wright CJ, Millar D K.H. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.//Cochrane Database Syst Rev. 2021. Vol. 30, N 11(11). P. CD012778.

84. Szyld E, Aguilar A, Musante GA, Vain N, Prudent L, Fabres J C.W. Delivery Room Ventilation Devices Trial Group. Comparison of devices for newborn ventilation in the delivery room.//J Pediatr. 2014. Vol. 165, N 2. P. 234 - 239.

85. Al. S.V. et. First intention high frequency oscillatory and conventional mechanical ventilation.//Early Hum. Dev. 2008. Vol. 84. P. С. S95.

86. Мостовой А.В., Карпова А.Л., Володин Н.Н. Б.Р.А. Эффективность и безопасность применения искусственной вентиляции легких с гарантированным объемом в родильном зале у детей с массой тела менее 750 г.//Анестезиология и реаниматология. 2021. Vol. 1. P. 46 - 54.

87. А.В. Мостовой, А.Л. Карпова, Н.Н. Володин Н.Ю.К. Применение высокочастотной искусственной вентиляции легких в родильном зале у недоношенных новорожденных детей с респираторным дистресс-синдромом.//Педиатрия им. Г.Н. Сперанского. 2021. Vol. 100, N 1. P. 17 - 23.

88. Карпова А.Л., Мостовой А.В., Межинский С.С., Южакова Е.А., Дудкина Е.А. Ф.М.А. Опыт внедрения ультразвуковых методов верификации положения эндотрахеальной трубки в неонатальную практику.//Педиатрия. 2018. Vol. 97, N 2. P. 200 - 206.

89. Sun H, Cheng R, Kang W, Xiong H, Zhou C, Zhang Y, Wang X Z.C. High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome.//Respir Care. 2014. Vol. 59, N 2. P. 159 - 169.

90. Klingenberg C, Wheeler KI, McCallion N, Morley CJ D.P. Volume-targeted versus pressure-limited ventilation in neonates.//Cochrane Database Syst Rev. 2017. Vol. 10, N 10. P. CD003666.

91. Cools F, Offringa M A.L. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.//Cochrane Database Syst Rev. 2015. Vol. 19, N 3. P. CD000104.

92. O'Connor K. L. D.M.W. Ventilation settings in preterm neonates with ventilator-dependant, evolving bronchopulmonary dysplasia.//Early Hum. Dev. 2021. Vol. 159. P. С. 105417.

93. Vaidya R., Visintainer P. S.R. Tidal volume measurements in the delivery room in preterm infants requiring positive pressure ventilation via endotracheal tube-feasibility study.//J. Perinatol. 2021. Vol. 41, N 8. P. С. 1930 - 1935.

94. Werther T. et al. Regular lung recruitment maneuvers during high-frequency oscillatory ventilation in extremely preterm infants: a randomized controlled trial.//BMC Pediatr. 2022. Vol. 22, N 1. P. С. 710.

95. Ferguson KN, Roberts CT, Manley BJ D.P. Interventions to improve rates of successful extubation in preterm infants: a systematic review and meta-analysis.//JAMA Pediatr. 2017. Vol. 171, N 2. P. 165 - 174.

96. Ионов О.В., Байбарина Е.Н. М.Т.С. Сравнение двух подходов к экстубации новорожденных с респираторным дистресс-синдромом и врожденной пневмонией.//Неонатология: новости, мнения, обучение. 2016. Vol. 1, N 11. P. 97 - 103.

97. Chen JY. Exogenous surfactant for treatment of respiratory distress syndrome in premature infants.//J Formos Med Assoc. 1990. Vol. 89, N 2. P. 110 - 114.

98. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L D.C. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial.//J Perinatol. 2005. Vol. 25, N 11. P. 703 - 708.

99. Horpaopan S, Sangtaveesin V R. V. Surfactant treatment in the neonate with severe respiratory distress syndrome.//J Med Assoc Thai. 1996. Vol. 79, N 4. P. 222 - 228.

100. Gortner L, Bartmann P, Pohlandt F, Bernsau U, Porz F, Hellwege HH, Seitz RC, Hieronimi G, Bremer C, Jorch G et al. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.//Pediatr Pulmonol. 1992. Vol. 14, N 1. P. 4 - 9.

101. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z C.C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.//Eur J Pediatr. 2003. Vol. 162, N 7 - 8. P. 476 - 480.

102. Dolfin T, Zamir C, Regev R, Ben Ari J W.B. Effect of surfactant replacement therapy on the outcome of premature infants with respiratory distress syndrome.//Isr J Med Sci. 1994. Vol. 30, N 4. P. 267 - 270.

103. Stevens TP, Harrington EW, Blennow M S.R. Early surfactant administration with brief ventilation versus selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.//Cochrane Database Syst Rev. 2007. Vol. 4. P. CD003063.

104. Abdel-Latif ME, Davis PG, Wheeler KI D., Paoli AG D.P. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.//Cochrane Database Syst Rev. 2021. Vol. 5, N 5. P. CD011672.

105. De Luca D de W.J. Less invasive surfactant administration: all that glitters is not gold.//Eur J Pediatr. 2020. Vol. 179, N 8. P. 1295 - 1296.

106. Dargaville PA, Kamlin COF, Orsini F W., X, De Paoli AG, Kanmaz Kutman HG et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST - A randomized clinical trial.//JAMA. 2021. Vol. 326, N 24. P. 2478 - 2487.

107. , Herting E, Humberg A H.K., Mehler K, Keller T et al. Association of administration of surfactant using less invasive methods with outcomes in extremely preterm infants less than 27 Weeks of gestation.//JAMA Netw Open. 2022. Vol. 5, N 8. P. e2225810.

108. Reynolds P, Bustani P, Darby C F., Alvarez JR, Fox G, Jones S et al. Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline.//Neonatology. 2021. Vol. 118, N 5. P. 586 - 592.

109. Herting E, Kribs A, C von der W., A, Weller U, Hoehn T et al. Two-year outcome data suggest that Less Invasive Surfactant Administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (Avoid Mechanical Ventilation) study.//Eur J Pediatr. 2020. Vol. 179, N 8. P. 1309 - 1313.

110. Federici C, Fornaro G R.C. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.//Eur J Hosp Pharm. 2022. Vol. 29, N 6. P. 346 - 352.

111. Krajewski P, Szpecht D H.R. Premedication practices for less invasive surfactant administration - results from a nationwide cohort study.//J Matern Fetal Neonatal Med. 2020. Vol. 25. P. 1 - 5.

112. Roberts KD, Brown R, Lampland AL L., TA, Rudser KD, Finer NN et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial.//J Pediatr. 2018. Vol. 193. P. 40 - 46. e1.

113. Gallup JA, Ndakor SM, Pezzano C P., JMB. Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in neonates born preterm.//J Pediatr. 2022. Vol. 3476, N 22. P. S002200891 - S002200895.

114. Gaertner VD, Thomann J, Bassler D R.C. Surfactant nebulization to prevent intubation in preterm infants: a systematic review and meta-analysis.//Pediatrics. 2021. Vol. 148, N 5. P. e2021052504.

115. Murphy MC, Galligan M, Molloy B H., R, Doran P O.C. Study protocol for the POPART study-prophylactic oropharyngeal surfactant for preterm infants: a randomised trial.//BMJ Open. 2020. Vol. 10, N 7. P. e035994.

116. Bahadue FL S.R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.//Cochrane Database Syst Rev. 2012. Vol. 11, N 11. P. CD001456.

117. Ramaswamy VV, Abiramalatha T, Bandyopadhyay T, Boyle E R.C. Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis.//Arch Dis Child Fetal Neonatal Ed. 2022. Vol. 107, N 4. P. 393 - 397.

118. Lanciotti L, Correani A, Pasqualini M, Antognoli L, Dell'Orto VG, Giorgetti C et al. Respiratory distress syndrome in preterm infants of less than 32 weeks: what difference does giving 100 or 200 mg/kg of exogenous surfactant make?//Pediatr Pulmonol. 2022. Vol. 57, N 9. P. 2067 - 2073.

119. Singh N, Halliday HL, Stevens TP S.G., Soll R R.-R.M. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.//Cochrane Database Syst Rev. 2015. P. CD010249.

120. Ramanathan R, Biniwale M, Sekar K H., N, Golombek S, Bhatia J et al. Synthetic surfactant CHF5633 compared with poractant alfa in the treatment of neonatal respiratory distress syndrome: a multicenter, doubleblind, randomized, controlled clinical trial.//J Pediatr. 2020. Vol. 225. P. 90 - 96. e1.

121. Справочник врача-неонатолога по неотложным состояниям у новорожденных детей. ГЭОТАР-Мед/ed. Киртбая А. Р Д.Д.Н. Москва, 2026. 360 p.

122. , Kribs A, , Dargaville P H.E. Less Invasive Surfactant Administration for Preterm Infants - State of the Art.//Neonatology. 2024. Vol. 121, N 5. P. 584 - 595.

123. Bancalari E., Claure N. The evidence for non-invasive ventilation in the preterm infant.//Arch. Dis. Child. Fetal Neonatal Ed. 2013. Vol. 98, N 2. P. 98 - 103.

124. Wright CJ, Glaser K, Speer CP H.C., Roehr CC. Noninvasive ventilation and exogenous surfactant in times of ever decreasing gestational age: how do we make the most of these tools?//J Pediatr. 2022. Vol. 247. P. 138 - 146.

125. Lavizzari A. et al. State of the art on neonatal noninvasive respiratory support: How physiological and technological principles explain the clinical outcomes.//Pediatr. Pulmonology. 2023. Vol. 58, N 9. P. 2442 - 2455.

126. Ионов О.В., Косинова Т.А., Киртбая А.Р., Балашова Е.Н., Зубков В.В. Б.Е.Н. Влияние времени вдоха на эффективность неинвазивной искусственной вентиляции легких с вариабельным потоком у недоношенных новорожденных//Неонатология: новости, мнения, обучение. 2019. Vol. 7, N 1 (23). P. 38 - 43.

127. А.В. Мостовой, К.В. Романенко, А.В. Аверин. Применение двухуровневого назального CPAP с вариабельным потоком у недоношенных новорожденных после экстубации: многоцентровое рандомизированное клиническое исследование.//Уральский медицинский журнал. 2014. Vol. 8, N 122. P. 143 - 150.

128. Schmidt B. et al. Long-Term Effects of Caffeine Therapy for Apnea of Prematurity//N. Engl. J. Med. 2007. Vol. 357, N 19. P. 1893 - 1902.

129. Miao Y., Liu W., Zhao S., Li Y., Jiang H., Wang A. et al. Effect of prophylactic caffeine in the treatment of apnea in very low birth weight infants: a meta-analysis.//J. Matern. Neonatal Med. Taylor Fr. 2023. Vol. 36, N 1. P. 2023. Vol. 36, N 1. P. 2214659.

130. Li X.L., Cai Y.J., Zhang Z., Li J., Chen X.W., Song Y.Y. Z.W. Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: A prospective randomized controlled trial.//Chinese J. Contemp. Pediatr. 2021. Vol. 23, N 11. P. 1097 - 1102.

131. Elmowafi M., Mohsen N., Nour I. N.N. Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial.//J. Matern. Neonatal Med. Taylor Fr. 2022. Vol. 35, N 25. P. P. 6053 - 6061.

132. Amaro C.M., Bello J.A., Jain D., Ramnath A., D'Ugard C., Vanbuskirk S. et al. Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants: A Randomized, Placebo-Controlled Trial.//J. Pediatr. Elsevier Inc. 2018. Vol. 196. P. 52 - 57.

133. Borszewska-Kornacka M.K., , Rutkowska M. L.R. Shifting the boundaries for early caffeine initiation in neonatal practice: Results of a prospective, multicenter study on very preterm infants with respiratory distress syndrome.//PLoS One. 2017. Vol. 12, N 1. P. 1 - 12.

134. Davis P.G., Schmidt B., Roberts R.S., Doyle L.W. A.E. Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups.//J. Pediatr. 2010. Vol. 156, N 3. P. 382 - 387.

135. Dobson N.R. R.M.P. The Role of Caffeine in Non-Invasive Respiratory Suppor.//Physiol. Behav. 2016. Vol. 43, N 4. P. 1 - 13.

136. Taha D., Kirkby S., Nawab U., Dysart K.C., Genen L., Greenspan J.S. A.Z.H. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.//J. Matern. Neonatal Med. 2014. Vol. 27, N 16. P. 1698 - 1702.

137. Du L., Tong X., Chen C., Gao X. G.A. Caffeine Citrate for Apnea of Prematurity: A Prospectiv, Open-Label, Single-Arm Study in Chinese Neonates.//Front. Pediatr. 2020. Vol. 8. P. 1 - 7.

138. Fakoor Z., Makooie A., Joudi Z. A.R. The effect of venous caffeine on the prevention of apnea of prematurity in the very preterm infants in the neonatal intensive care unit of Shahid Motahhari Hospital, Urmia, during a year.//J. Adv. Pharm. Technol. Res. 2019. Vol. 10, N 1. P. P. 16.

139. Armanian A.M., Iranpour R., Faghihian E. S.N. Caffeine Administration to Prevent Apnea in Very Premature Infants.//Pediatr. Neonatol. Elsevier Taiwan LLC. 2016. Vol. 57, N 5. P. 408 - 412.

140. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes//Cochrane Database Syst. Rev. 2013. Vol. 2013, N 12.

141. Capin I, Hinds A, Vomero B, Roth P B.J. Are Early-Onset Sepsis Evaluations and Empiric Antibiotics Mandatory for All Neonates Admitted with Respiratory Distress?//Am J Perinatol. 2022. Vol. 39, N 4. P. 444 - 448.

142. Korang SK, Safi S, Nava C, Gordon A, Gupta M, Greisen G L.-T.U.J.J. Antibiotic regimens for early-onset neonatal sepsis.//Cochrane Database Syst. Rev. 2021. Vol. 5. P. P. CD013837.

143. Puopolo KM B.W.Z.T. Committee on fetus and newborn; committee on infectious diseases. Management of Neonates Born at 35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.//Pediatrics. 2018. Vol. 142, N 6. P.. e20182894.

144. Puopolo KM B.W.Z.T. Committee on fetus and newborn; committee on infectious diseases. Management of Neonates Born at 34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.//Pediatrics. 2018. Vol. 142, N 6. P. P. e20182896.

145. Антимикробная терапия у детей. Практическое руководство. ГЭОТАР-Мед/ed. Шухов В.С., Байбарина Е.Н. Р.И.И. Москва, 2016. 320 p.

146. Quigley M., McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants//Cochrane Database Syst. Rev. 2014. Vol. 2014, N 4.

147. Boscarino G. et al. Early enteral feeding improves tolerance of parenteral nutrition in preterm newborns.//Nutrients. 2021. Vol. 13, N 11. P. С. 3886.

148. Ионов О.В., Костерина Е.Е., Киртбая А.Р., Балашова Е.Н., Красный А.М., Петрова А.С., Грызунова А.С., Обрубов Д.И., Малютина Л.В., Серова О.Ф. З.В.В. Проградиентное наращивание объема энтерального кормления у недоношенных новорожденных: предварительные результаты мультицентрового проспективного сравнительного рандомизированного исследования.//Вопросы практической педиатрии. 2022. Vol. 17, N 1. P. 113 - 121.

149. Костерина Е.Е., Ионов О.В., Киртбая А.Р., Балашова Е.Н., Шарафутдинова Д.Р., Красный А.М., Петрова А.С., Грызунова А.С., Обрубов Д.И., Серова О.Ф. З.В.В. Проградиентное форсированное наращивание объема энтерального питания у глубоконедоношенных детей: результаты мультицентрового проспективного рандомизированного исследования.//Неонатология: новости, мнения, обучение. 2023. Vol. 11, N 2 (40). P. 12 - 29.

150. Osborn D. A. et al. Higher versus lower amino acid intake in parenteral nutrition for newborn infants.//Cochrane Database Syst. Rev. 2018. Vol. 3.

151. Kim K., Kim N. J. K.S.Y. Safety and efficacy of early high parenteral lipid supplementation in preterm infants: a systematic review and meta-analysis.//Nutrients. 2021. Vol. 13, N 5. P. С. 1535.

152. Moyses H. E. et al. Early parenteral nutrition and growth outcomes in preterm infants: a systematic review and meta-analysis.//Am. J. Clin. Nutr. 2013. Vol. 97, N 4. P. С. 816 - 826.

153. Al. V.H. et. Albumin synthesis in very low birth weight infants is enhanced by early parenteral lipid and high-dose amino acid administration.//Clin. Nutr. 2016. Vol. 35, N 2. P. С. 344 - 350.

154. Vlaardingerbroek H. et al. Safety and efficacy of early parenteral lipid and high-dose amino acid administration to very low birth weight infants.//J. Pediatr. 2013. Vol. 163, N 3. P. С. 638 - 644.

155. van Goudoever J.B. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids.//Clin. Nutr. 2018. Vol. 3, N 6. P. P. 2315 - 2323.

156. Mesotten D. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates.//Clin. Nutr. 2018. Vol. 37, N 6. P. P. 2337 - 2343.

157. Jochum F. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes.//Clin. Nutr. 2018. Vol. 37, N 6. P. P. 2344 - 2353.

158. Lapillonne A. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids.//Clin. Nutr. 2018. Vol. 37, N 6. P. P. 2324 - 2336.

159. Joosten K. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy.//Clin. Nutr. 2018. Vol. 37, N 6. P. P. 2309 - 2314.

160. Ancora G. et al. Efficacy and safety of continuous infusion of fentanyl for pain control in preterm newborns on mechanical ventilation.//J. Pediatr. 2013. Vol. 163, N 3. P. С. 645 - 651.

161. McPherson C O.K. Provision of Sedation and Treatment of Seizures During Neonatal Therapeutic Hypothermia.//Neonatal Netw. 2020. Vol. 39, N 4. P. 227 - 235.

162. Rautava L. et al. 5-Year Morbidity Among Very Preterm Infants in Relation To Level of Hospital Care//Arch. Pediatr. Adolesc. Med. 2013. Vol. 167, N 1. P. 40 - 46.

163. Российское общество акушеров-гинекологов. Клинические рекомендации. Преждевременные роды. 2024.

164. Roberts D, Brown J, Medley N D.S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.//Cochrane Database Syst Rev. 2017. Vol. 3, N 3.

165. Msan A. K. et al. Use of antenatal corticosteroids in the management of preterm delivery.//Am. J. Perinatol. 2015. Vol. 32, N 5. P. 417 - 426.

166. Crowther CA, Middleton PF, Voysey M,Askie L, Zhang S, Martlow TK et al. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: an individual participant data meta-analysis.//PLoS Med. 2019. Vol. 16, N 4. P. e1002771.

167. Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S et al. Multiplecourses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).//JAMA Pediatr. 2013. Vol. 167, N 12. P. 1102 - 1110.

168. Raju T. Timing of umbilical cord clamping after birth//Pediatrics. 2013. Vol. 131, N 4. P. 1522 - 1526.

169. Rabe H. et al. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes//Cochrane Database Syst. Rev. 2019. Vol. 2019, N 9.

170. Fogarty M. et al. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis//Am. J. Obstet. Gynecol. Elsevier Inc., 2018. Vol. 218, N 1. P. 1 - 18.

171. Katheria A. et al. Association of umbilical cord milking vs delayed umbilical cord clamping with death or severe intraventricular hemorrhage among preterm infants//JAMA - J. Am. Med. Assoc. 2019. Vol. 322, N 19. P. 1877 - 1886.

172. Al. V.N.E. et. Effect of gravity on volume of placental transfusion: a multicentre, randomised, non-inferiority trial.//The Lancet. 2014. Vol. 384, N 9939. P. 235 - 240.

173. Fogarty M. et al. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis.//Am. J. Obstet. Gynecol. 2018. Vol. 218, N 1. P. 1 - 18.

174. Shirk S. K. et al. Delayed clamping vs milking of umbilical cord in preterm infants: a randomized controlled trial.//Am. J. Obstet. Gynecol. 2019. Vol. 220, N 5. P. 482.

175. Jochum F. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes//Clin. Nutr. 2018. Vol. 37, N 6. P. 2344 - 2353.

176. van Goudoever J.B. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids//Clin. Nutr. 2018. Vol. 37, N 6. P. 2315 - 2323.

177. Lapillonne A. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids//Clin. Nutr. 2018. Vol. 37, N 6. P. 2324 - 2336.

178. Mesotten D. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates//Clin. Nutr. 2018. Vol. 37, N 6. P. 2337 - 2343.

179. Joosten K. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy//Clin. Nutr. 2018. Vol. 37, N 6. P. 2309 - 2314.

180. Mihatsch W. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium//Clin. Nutr. 2018. Vol. 37, N 6. P. 2360 - 2365.

181. Hedstrom AB, Gove NE, Mayock DE B.M. Performance of the Silverman Andersen Respiratory Severity Score in predicting PCO2 and respiratory support in newborns: A prospective cohort study.//J. Perinatol. 2018; 38505-11. 2018. Vol. 38. P. Journal of Perinatology 2018; 38: 505 - 511.

182. E. Baibarina, O. Borisevich O.I. Abstracts. New NCPAP Protocol: a comparison of results before and after implementation.//J. Matern. Neonatal Med. 2012. Vol. 25. P. 109.

183. Cavallin F, Balestri E, Calia M et al. Training on the Silverman and Andersen score improved how special care unit nurses assessed neonatal respiratory distress in a low-resource setting.//Acta Paediatr. 2022. Vol. 111. P. 1866 - 1869.

184. Elena Baibarina, Albert Antonov, Oleg Ionov O.B. Criteria for intubation and mechanical ventilation in infants on NCPAP (abstract).//J. Perinat. Med. 2009. Vol. 37. P. 767.

185. McAdams RM, Hedstrom AB, DiBlasi RM et al. Implementation of Bubble CPAP in a Rural Ugandan Neonatal ICU.//Respir Care. 2015. Vol. 60. P. 437 - 445.